NCT01660529View on ClinicalTrials.gov

Multi-peptide Vaccine With Basilixumab for Breast Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

November 20, 2015

Study Completion Date

November 20, 2015

Conditions
Metastatic Breast Cancer
Interventions
BIOLOGICAL

hTERT

Trial Locations (1)

19104

Abramson Cancer Center, University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT01660529 - Multi-peptide Vaccine With Basilixumab for Breast Cancer | Biotech Hunter | Biotech Hunter